Literature DB >> 24900667

Inhibition of mTOR Kinase and Cancer Treatment.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2013        PMID： 24900667      PMCID： PMC4027238          DOI： 10.1021/ml400056x

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  mTor as a potential target for the prevention and treatment of hepatocellular carcinoma.

Authors:  Laura Elisa Buitrago-Molina; Arndt Vogel
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

Review 2.  Dissecting the role of mTOR: lessons from mTOR inhibitors.

Authors:  Ryan J O Dowling; Ivan Topisirovic; Bruno D Fonseca; Nahum Sonenberg
Journal:  Biochim Biophys Acta       Date:  2009-12-11

3.  mTOR inhibitors: A novel class of anti-cancer agents.

Authors:  Haris Riaz; Talha Riaz; Syed A Hussain
Journal:  Infect Agent Cancer       Date:  2012-01-03       Impact factor: 2.965
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.